King of Prussia, PA (PRWEB) May 15, 2013
A CMI/Compas survey of physicians’ perceptions of DTC advertising finds that it does influence their prescribing habits, and yet still is not as valuable or informational as it could be.
In 2002, the FDA conducted a study of HCPs to understand their attitudes and behaviors associated with DTC advertising of prescription drugs, and recently announced they will be conducting the study again. On April 25, 2013, CMI/Compas conducted a ByDoctor® PULSE™ study of physicians using questions to gauge HCP perceptions. ByDoctor PULSE is a rapid response marketing research tool that provides instant audience insights around key campaign questions.
A sampling of the findings:
The survey included 104 physicians across multiple specialties. For a free copy of full findings or to learn more about how ByDoctor® PULSE™ can help you engage your prescriber audiences, please contact Lindsay Dinan at ldinan(at)cmicompas(dot)com.
Well-known as a media planning and buying organization for healthcare clients, sister agencies Communications Media, Inc. (CMI) and Compas, Inc. together form the indispensable strategic marketing partner to the world’s game-changers in health, offering guidance at every level of marketing. CMI/Compas focuses on core service offerings of Media, Innovation, Customer Insights, Technology, and Buying. CMI/Compas is laser-focused on helping clients move the promotional needle. CMI/Compas has offices in Philadelphia; King of Prussia, PA; Pennsauken, NJ; and New York. The family of companies is actively recruiting for healthcare marketing jobs via http://www.cmirecruiter.com.